RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GAIDANO G
Collezione AO Cuneo

Items : 8

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.

2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Vitale C; Coscia M; Bruno B; Rambaldi A; Laurenti L; Krampera M; Gaidano G; Rivela P; Quaresmini G; Quaglia FM; Moia R; Innocenti I; Deodato M; Frustaci AM; Catania G; Boccellato E; Montalbano MC; Perutelli F;

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. in British journal of haematology / Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.

2022
AOU Alessandria
AO Cuneo

Massaia M; Ladetto M; Pistello M; Lai M; Rapezzi D; Marchetti M; Gaidano V; Ucciero MAM; Mahmoud AM; Patriarca A; Ferrante D; De Andrea M; Martuscelli L; Griffante G; Borgogna C; Bruna R; Gaidano G; Gariglio M; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M; Ferrante D; Patriarca A; Mahmoud AM; Ucciero MAM; Gaidano V; Marchetti M; et alii...

Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. in British journal of haematology / Br J Haematol. 2022 Mar;196(5):1184-1193. doi: 10.1111/bjh.17971. Epub 2021 Dec 23.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Gaidano G; Vitolo U; Pileri SA; Tucci A; Balzarotti M; Ladetto M; Santambrogio E; Righi S; Melle F; Moia R; Motta G; Martelli M; Ciccone G; Di Rocco A; Evangelista A; Nassi L; Novo M; Agostinelli C; Chiappella A; Diop F;

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. in Blood cancer journal / Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.

2022
AOU Alessandria
AO Cuneo

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Gaidano V; Mahmoud AM; Patriarca A; Ferrante D; Griffante G; Martuscelli L; De Andrea M; Borgogna C; Bruna R;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Coscia M; Foà R; Massaia M; Gaidano G; Bernardi R; Gattei V; Zenz T; Mauro FR; Del Poeta G; Laurenti L; Omedè P; Kodipad AA; Marchetti M; Bonello L; Magliulo D; Bo MD; Pozzato G; Rossi D; Bomben R; Riganti C; Salvetti C; Kopecka J; Todaro M; Vitale C; Griggio V; Boccadoro M;

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

2016
AO Cuneo

De Stefano V; Ruggeri M; Cervantes F; Alvarez-Larrán A; Iurlo A; Randi ML; Elli E; Finazzi MC; Finazzi G; Zetterberg E; Vianelli N; Gaidano G; Rossi E; Betti S; Nichele I; Cattaneo D; Palova M; Ellis MH; Cacciola R; Tieghi A; Hernandez-Boluda JC; Pungolino E; Specchia G; Rapezzi D; Forcina A; Musolino C; Carobbio A; Griesshammer M; Sant'Antonio E; et alii...

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. in Blood cancer journal / Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

2016
AO Cuneo

De Stefano V; Vannucchi AM; Ruggeri M; Cervantes F; Alvarez-Larrán A; Iurlo A; Randi ML; Pieri L; Rossi E; Guglielmelli P; Betti S; Elli E; Finazzi MC; Finazzi G; Zetterberg E; Vianelli N; Gaidano G; Nichele I; Cattaneo D; Palova M; Ellis MH; Cacciola E; Tieghi A; Hernandez-Boluda JC; Pungolino E; Specchia G; Rapezzi D; Forcina A; Musolino C; et alii...

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.

2014
AO Cuneo

Montillo M; Tedeschi A; Gaidano G; Coscia M; Petrizzi VB; Orlandi E; Cascavilla N; Ghia P; Motta M; Gallamini A; Frustaci AM; Rossi D; De Paoli L; Nichelatti M; Morra E; Massaia M;